IRF5 and psoriasis: The findings underscore the critical role of m6A RNA modification in psoriasis pathogenesis and unveil a novel regulatory mechanism of TASL‐IRF5 signaling through m6A modification, suggesting potential new therapeutic targets for psoriasis treatment.